Fig. 2.
![Fig. 2. Sensitivity to three cysteine proteinase inhibitors (0.1 mmol/L HgCl2, 0.2 mmol/L ZAA-diazomethyl-ketone, and 1 mmol/L IodoAcetic acid [IA]), and to the TF inhibitor anti-TF MoAb (0.1 mg/mL final concentration) of the PCA of S-NB4 (left) and R-NB4-306 cells (right) treated with 10−6 mol/L ATRA (▪) or the vehicle (□) for 96 hours. VB cell extracts were incubated with cysteine proteinase inhibitors or the anti-TF MoAb for 30 minutes or the vehicle (control), before the clotting assay. Statistical analysis compares the inhibitor-treated sample with the untreated (vehicle treated) corresponding control. *P < .05, **P < .01.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/92/1/10.1182_blood.v92.1.143.413k18_143_151/5/blod41318002x.jpeg?Expires=1724151934&Signature=zrPiBdqWT2kNQ46MhXyZzNmtxspbJogdC7LGCKT03wNzQL9g9ZUdxY6v4yMcTYesVn~mUz5Ab75oykWbNHWoN-BTrSXKslGp94ObXFR7jHIjv667xvrc6nDy6jm~SHjkqmZo5oy29rAoonaiY5f4EbCdRo-q0x0v56RaKlBi179A2sICIDBocKZ0hdiX3PHVQWryat2iRfu-CyTR~sHNQbLXYpbBt7Y4Ig~G5632asFlfWZWmszsbVLJRc2ZcGMu9Ew3g0Moymy~1I748vwxRMZtztXrj4OpT-h8843wl-1Yv71C1mcQKYLBr4jhLjXcCJ9RaoJF-sQu2zMK9B5rdA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Sensitivity to three cysteine proteinase inhibitors (0.1 mmol/L HgCl2, 0.2 mmol/L ZAA-diazomethyl-ketone, and 1 mmol/L IodoAcetic acid [IA]), and to the TF inhibitor anti-TF MoAb (0.1 mg/mL final concentration) of the PCA of S-NB4 (left) and R-NB4-306 cells (right) treated with 10−6 mol/L ATRA (▪) or the vehicle (□) for 96 hours. VB cell extracts were incubated with cysteine proteinase inhibitors or the anti-TF MoAb for 30 minutes or the vehicle (control), before the clotting assay. Statistical analysis compares the inhibitor-treated sample with the untreated (vehicle treated) corresponding control. *P < .05, **P < .01.
